Description
EMPAGOOD 25 L Tablets (30’s pack) combine 25mg of Empagliflozin and 5mg of Linagliptin to provide effective management of type 2 diabetes mellitus. Empagliflozin, an SGLT2 inhibitor, lowers blood glucose by promoting its excretion through the kidneys, while Linagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces glucagon levels to maintain optimal blood sugar balance.
This combination offers improved glycemic control, supports weight management, and may reduce the risk of cardiovascular complications. The 30-tablet pack ensures a convenient supply for ongoing treatment.
Manufactured under strict quality standards, EMPAGOOD 25 L Tablets deliver safety, efficacy, and consistent therapeutic results. Patients should follow their healthcare provider’s guidance and adopt a healthy lifestyle for maximum benefit.
Reviews
There are no reviews yet.